Professor Dame Anna Dominiczak
Regius Professor of Medicine, Vice Principal and Head of College of Medical, Veterinary and Life Sciences
‘At the University of Glasgow, we continue to champion the importance of a precision medicine approach to health care where research and industry collaborators work closely together. We are proud to house the Stratified Medicine Scotland Innovation Centre, an area that has been purpose built to bring world-leading research and innovative industry together.’
Professor Dame Anna Dominiczak is Regius Professor of Medicine, Vice Principal and Head of College of Medical, Veterinary and Life Sciences at the University of Glasgow as well as honorary consultant physician and non-executive member of the NHS Greater Glasgow and Clyde Health Board. In 2016, she was awarded a DBE for her services to cardiovascular and medical science.
Professor Dominiczak is one of the world’s leading cardiovascular scientists and clinical academics. She held a British Heart Foundation Chair of Cardiovascular Medicine at the University of Glasgow between 1997 and 2010, as well as the directorship of the Cardiovascular Research Centre between 2000 and 2010. Her major research interests are in hypertension, cardiovascular genomics and precision medicine, where she has not only published extensively in top peer-reviewed journals (almost 400 publications), but also excelled in large scale research funding for programmes and infrastructure alike (with a total value of over £70M in the last five years). She has also led a collaboration of four universities, four academic NHS Health Boards across Scotland and two major industrial partners to develop a public/private partnership in Precision Medicine with a current value in excess of £20M.
Professor Dominiczak is a Fellow of the Royal College of Physicians, the Academy of Medical Sciences, the Royal Society of Edinburgh, the American Heart Association and the European Society of Cardiology as well as a member of the Association of Physicians of Great Britain and Ireland, the European Society of Hypertension and the International Society of Hypertension. In 2012, she was invited to join the Council of the Academy of Medical Sciences and elected Vice President, Life Sciences of the Royal Society of Edinburgh. She was President of the European Society of Hypertension from 2013 to 2015.
Since 2012, she has been Editor-in-Chief of Hypertension, the journal of the American Heart Association and the world’s top journal in her area of research.